Can drug repurposing uncover better treatments for UTIs?
Growing antibiotic resistance and chronic urinary tract infections have illustrated the need for new, effective treatments for UTIs.
By
Women's Health
Latest in
Women's Health
EC grants approval for Merck-Eisai’s combo therapy for endometrial cancer
The approval is based on positive data from the Phase III KEYNOTE-775/Study 309 trial of Keytruda plus Lenvima.
UK Parliament endometriosis/PCOS debate concludes: what are the implications?
The recent UK Parliament debate did not suggest more near-term funding for endometriosis and polycystic ovary syndrome (PCOS).
By
Organon to acquire drug development company Forendo Pharma
Forendo’s lead therapy being developed to treat endometriosis is ready to enter Phase II trial.
Cervical cancer: real-world data highlights value of HPV vaccine market
A recent study found that the UK’s HPV vaccine programme has dramatically reduced cervical cancer rates in the country.
By
Merck’s Keytruda obtains EC approval for breast cancer
With the approval, the combination treatment will be marketed in all 27 member states of the EU.
Endometriosis in Hollywood: Amy Schumer’s surgery highlights need for novel therapies
The actress and comedian’s difficult and extensive surgery is a reminder of the gap in endometriosis treatment and patient need.
By
Study identifies possible link between antibiotic use and breast cancer growth
Researchers have investigated how disrupting a healthy balance of bacteria in the gut impacts breast cancer growth in mice.
By